Samatasvir
Samatasvir
Samatasvir (pronunciation: sa-ma-tas-vir) is an experimental antiviral drug that was under development for the treatment of Hepatitis C. It is a member of the class of drugs known as NS5A inhibitors, which work by blocking a specific protein that the Hepatitis C virus needs to replicate.
Etymology
The name "Samatasvir" is derived from the Sanskrit word "Samata", meaning "equality" or "balance", and "vir", a common suffix in antiviral drug names. The name reflects the drug's intended function of restoring balance to the body by fighting off the Hepatitis C virus.
Related Terms
- Antiviral drug: A type of medication used specifically for treating viral infections.
- Hepatitis C: A viral infection that causes liver inflammation, sometimes leading to serious liver damage.
- NS5A inhibitors: A class of antiviral drugs that inhibit the replication of the Hepatitis C virus.
See Also
- Daclatasvir: Another NS5A inhibitor used in the treatment of Hepatitis C.
- Ledipasvir: An NS5A inhibitor that is often used in combination with other drugs to treat Hepatitis C.
External links
- Medical encyclopedia article on Samatasvir
- Wikipedia's article - Samatasvir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski